Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Preoperative Ultrasound-Guided Bilateral Greater Occipital Nerve Block on Postoperative Headache Following Endovascular Coiling of Unruptured Intracranial Aneurysms: A Prospective, Randomized, Sham-Controlled Trial

NCT07910864 is registered in ClinicalTrials.gov with Konya City Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07910864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Preoperative Ultrasound-Guided Bilateral Greater Occipital Nerve Block on Postoperative Headache Following Endovascular Coiling of Unruptured Intracranial Aneurysms: A Prospective, Randomized, Sham-Controlled Trial
Lead sponsor
Konya City Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 2, 2026
Completion date
December 2, 2027
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 2 arms.

  • Postoperative headache is a common complication following endovascular coil embolization of intracra ExperimentalUltrasound-Guided Bilateral Greater Occipital Nerve Block

    Participants assigned to the experimental group will receive preoperative ultrasound-guided bilateral greater occipital nerve block with 0.25% bupivacaine before induction of general anesthesia.

    A total of 3 mL of 0.25% bupivacaine (7.5 mg) will be administered on each side into the interfascial plane between the semispinalis capitis and obliquus capitis inferior muscles. The total bilateral dose will be 15 mg of bupivacaine in 6 mL.

    The intervention will be performed while the patient is awake and able to communicate, without routine deep sedation.

    All participants will subsequently receive standardized general anesthesia and postoperative multimodal analgesia.

  • Bilateral Superficial Sham Injection Sham comparatorBilateral Superficial Subcutaneous Sham Injection

    Participants assigned to the control group will receive bilateral superficial subcutaneous sham injections with 0.9% normal saline before induction of general anesthesia.

    Following the same general preparation, positioning, and ultrasound examination as the experimental group, 0.5 mL of 0.9% normal saline will be injected subcutaneously on each side of the occipital region using a short 27-gauge needle.

    The total bilateral injection volume will be 1 mL.

    The needle will not be advanced into the deep interfascial plane, and no injection will be performed around the greater occipital nerve.

    All participants will receive standardized general anesthesia and postoperative multimodal analgesia.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Time-Weighted Average Resting Pain Score During the First 24 Postoperative Hours From postoperative hour 0 to postoperative hour 24

    Postoperative resting pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain).

    NRS scores will be recorded at postoperative hours 0, 2, 4, 6, 8, 12, and 24.

    The area under the NRS pain score-time curve (AUC0-24) will be calculated using the linear trapezoidal method and divided by 24 hours to obtain the time-weighted average NRS score.

    The resulting patient-level value will range from 0 to 10, with higher scores indicating greater overall postoperative pain intensity.

Lead sponsor's other trials

Konya City Hospital, most recent start first.

Similar trials

Same condition (Intracranial Aneurysm) and phase, most recent start first.